| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 10/24/2013 | US20130281417 Implants and methods for treating inflammation-mediated conditions of the eye |
| 10/24/2013 | US20130281415 NEW CYCLOHEXYLAMINE DERIVATIVES HAVING ß2 ADRENERGIC AGONIST AND M3 MUSCARINIC ANTAGONIST ACTIVITIES |
| 10/23/2013 | EP2653468A1 Bicyclic Compound and Use Thereof for Medical Purposes |
| 10/23/2013 | EP2653193A1 Method for treating macular degeneration |
| 10/23/2013 | EP2653159A1 Bromfenac organic salts and preparation method, composition and use thereof |
| 10/23/2013 | EP2653157A1 Astaxanthin for improving muscle atrophy |
| 10/23/2013 | EP2651403A2 Use of lp-pla2 inhibitors in the treatment and prevention of eye diseases |
| 10/23/2013 | CN103360354A New compound for preparation of eye drops |
| 10/23/2013 | CN103357017A Application of met-RANTES in preparing medicine used for treating inherited retinal degeneration |
| 10/23/2013 | CN103356983A Drug for treating tinnitus and deafness and preparation method thereof |
| 10/23/2013 | CN103356960A Decoction for treatment of jaundice |
| 10/23/2013 | CN103356699A Natural salt lake brine drop for treating tympanitis, and preparation method thereof |
| 10/23/2013 | CN103356695A Relieving water for nourishing liver to improve visual acuity |
| 10/23/2013 | CN103356640A Application of glucocorticoid in preparation of medicine used for treating and alleviating Graves ophthalmopathy |
| 10/23/2013 | CN103356514A Diarylalkanes as potent inhibitors of binuclear enzymes |
| 10/23/2013 | CN103356481A Ophthalmic emulsions containing immunosuppressive agent |
| 10/23/2013 | CN102671043B Traditional Chinese medicine for treating children chronic otitis media with effusion, as well as preparation method and application thereof |
| 10/23/2013 | CN102233132B Application of VEGF acceptor fusion proteins in preparation of drugs for inhibiting growth of ocular surface neovascularization |
| 10/23/2013 | CN101679298B Fused bicyclic heteroaryl derivatives |
| 10/22/2013 | US8563538 Preventing and/or treating cardiovascular disease and/or associated heart failure |
| 10/22/2013 | US8563011 Use of low molecular weight amino alcohols in ophthalmic compositions |
| 10/22/2013 | US8562977 Human aminoacyl-tRNA synthetase polypeptides useful for the regulation of angiogenesis |
| 10/22/2013 | US8562952 Methods for manipulating satiety |
| 10/22/2013 | CA2599112C Composition comprising dihomo-.gamma.-linolenic acid (dgla) as the active ingredient |
| 10/22/2013 | CA2528179C Piperidinyl prostaglandin e analogs |
| 10/22/2013 | CA2412626C Il-17 molecules and uses thereof |
| 10/17/2013 | WO2013155381A1 Treatment for microbe-induced inflammatory responses in the eye |
| 10/17/2013 | WO2013154209A1 Antiprotozoan composition containing caspofungin or its salt and biguanide compound or its salt |
| 10/17/2013 | WO2013154016A1 Ophthalmic composition |
| 10/17/2013 | US20130274689 Method for Reducing or Preventing Transplant Rejection in the Eye and Intraocular Implants for Use Therefor |
| 10/17/2013 | US20130273004 Substituted alkylamine derivatives and methods of use |
| 10/16/2013 | EP2650021A1 Medical device for controlled release of drug |
| 10/16/2013 | EP2649066A1 Hydantoin derivatives useful as kv3 inhibitors |
| 10/16/2013 | EP2649046A1 [((1r,2s,5r)-2-isopropyl-5-methyl-cyclohexanecarbonyl)-amino]-acetic acid isopropyl ester and related compounds and their use in therapy |
| 10/16/2013 | EP2648713A1 Dosages of arylsulfonamide derivatives |
| 10/16/2013 | EP2648712A1 Arylsulfonamide derivatives for the prevention or treatment of specific ophthalmologic disorders |
| 10/16/2013 | EP2648711A2 Compositions and methods for treating ophthalmic conditions |
| 10/16/2013 | EP2648705A1 Oral care compositions comprising a quinone and a further antimicrobial agent |
| 10/16/2013 | CN103351308A Positively charged water-soluble 4-acetamidophenol having rapid skin penetration speed, and related compound prodrug thereof |
| 10/16/2013 | CN103349781A Modified chimeric polypeptides with improved pharmacokinetic properties |
| 10/16/2013 | CN103349777A Crig polypeptide used for prevention and treatment of related disorder of alexin |
| 10/16/2013 | CN103349732A Dendrobium officinale kimura et migo-panax quinquefolius buccal tablets for diabetes patients, and preparation method thereof |
| 10/16/2013 | CN103349723A Chinese herbal preparation for presbycusis and preparation method of preparation |
| 10/16/2013 | CN103349714A Traditional Chinese medicine for treating tinnitus |
| 10/16/2013 | CN102716074B Bimatoprost eye drops and preparation method thereof |
| 10/16/2013 | CN102698079B Medicine composition for treating xerophthalmia and preparation method and application thereof |
| 10/16/2013 | CN102641242B Method for preparing composite phospholipid sterol lipid |
| 10/16/2013 | CN101935301B Modulators of ATP-binding cassette transporters |
| 10/16/2013 | CN101623377B Digitalis extract as well as preparation method and application thereof |
| 10/15/2013 | US8557855 Methods of using ryanodine antagonists in treating neural injury |
| 10/15/2013 | US8557796 Substituted 1-oxa-2,8-diaza-spiro [4,5] dec-2-ene derivatives and related treatment methods |
| 10/15/2013 | US8557240 Method for the treatment of inflammatory disorders |
| 10/10/2013 | WO2013151699A1 Composition and method for corneal proliferation |
| 10/10/2013 | WO2013150292A1 Composition for the treatment of inflammatory and immune disorders |
| 10/10/2013 | WO2013149986A1 Use of ccr3-inhibitors |
| 10/10/2013 | WO2013090842A3 Ophthalmic compositions comprising polyvinyl caprolactam - polyvinyl acetate - polyethylene glycol graft copolymers (soluplus) |
| 10/10/2013 | US20130266553 Albumin Fusion Proteins |
| 10/09/2013 | EP2647382A1 Compositions and methods for treating epithelial and retinal tissue diseases |
| 10/09/2013 | EP2647373A1 Methods for preventing the development of retinopathy by the oral administration of exo-S-mecamylamine. |
| 10/09/2013 | EP2646449A1 Uridine di- or tri-phosphate derivatives and uses thereof |
| 10/09/2013 | EP2646415A1 Novel azetidine derivatives as sphingosine 1-phosphate (s1p) receptor modulators |
| 10/09/2013 | EP2646405A1 Alkyne and alkene derivatives as sphingosine 1-phosphate-1 receptor modulators |
| 10/09/2013 | EP2646034A1 Methods for treating diseases of the retina |
| 10/09/2013 | EP2646030A1 Pharmaceutical compositions comprising 3,4- dihydroisoquinolin-2(1 h)-yl-3-phenylurea derivatives having formyl peptide receptor like-1 (fprl-1) agonist or antagonist activity |
| 10/09/2013 | EP2646012A2 Selective, lipophilic, and long-acting beta agonist monotherapeutic formulations and methods for the cosmetic treatment of adiposity and contour bulging |
| 10/09/2013 | EP2646007A2 Cell lines that secrete anti-angiogenic antibody-scaffolds and soluble receptors and uses thereof |
| 10/09/2013 | CN103343075A Health-keeping and healthcare medicinal liquor and preparation method thereof |
| 10/09/2013 | CN103342700A 11[beta]-hydroxysteroid dehydrogenase type 1 inhibitor |
| 10/09/2013 | CN103341159A Application of immune regulation markers TIPE2 (Tumor Necrosis Factor-a Induced Protein 8 like 2) in preparation of medicine used for treating vascular proliferation diseases |
| 10/09/2013 | CN103341112A Traditional Chinese medicine for treating scleritis |
| 10/09/2013 | CN103341020A Traditional Chinese medicine preparation for treating radiation cataract and preparation method thereof |
| 10/09/2013 | CN103340992A Eye ointment for adjusting eyesight |
| 10/09/2013 | CN103340949A Eye drops for removing nebula and cataract |
| 10/09/2013 | CN103340911A Health care product capable of resisting visual fatigue |
| 10/09/2013 | CN103340901A Eyedrop with all natural ingredients as well as preparation method and using method of eyedrop |
| 10/09/2013 | CN103340878A Compound ofloxacin solution for veterinary use and preparation process of compound ofloxacin solution |
| 10/09/2013 | CN103340846A Arachidonic acid soft capsule and preparation method |
| 10/09/2013 | CN103340845A 药物组合物 The pharmaceutical composition of |
| 10/09/2013 | CN102940867B Chinese medicinal composition for treating xerophthalmia |
| 10/09/2013 | CN102935162B Pills for retrobulbar neuritis and preparation method |
| 10/09/2013 | CN102860942B Nursing compound essential oil for eyes |
| 10/09/2013 | CN102218145B Medicinal composition for protecting optic nerve of glaucoma and preparation method thereof |
| 10/08/2013 | US8552062 Methods for the treatment of metabolic disorders such as diabetes |
| 10/08/2013 | US8552015 Quinazolinone derivatives and their use as CB agonists |
| 10/08/2013 | US8551952 Methods for the treatment and prevention of ocular disorders |
| 10/08/2013 | US8551516 Administration of non-oral androgenic steroids to women |
| 10/08/2013 | CA2710506C Use of aqueous solutions of ascorbic acid in the treatment of disorders of the eustachian tube |
| 10/08/2013 | CA2680222C Methods of treating ophthalmic diseases |
| 10/08/2013 | CA2602573C Protective agent for retinal neuronal cell containing prostaglandin f2 .alpha. derivative as active ingredient |
| 10/03/2013 | WO2013149260A1 Method for treatment of ocular disorders |
| 10/03/2013 | WO2013148896A1 Ocular treatment solutions, delivery devices and delivery augmentation methods |
| 10/03/2013 | WO2013148305A1 Method for treating diabetic retinopathy |
| 10/03/2013 | WO2013147556A1 Pharmaceutical composition for preventing or treating hearing loss, containing cilostazol and ginkgo leaf extract as active ingredients |
| 10/03/2013 | WO2013147140A1 Nucleic acid molecule capable of inhibiting expression of periostin gene, method for inhibiting expression of periostin gene, and use of said nucleic acid molecule |
| 10/03/2013 | WO2013147000A1 Aqueous composition containing 2-amino-3-(4-bromobenzoyl)- phenylacetic acid |
| 10/03/2013 | WO2013146754A1 Aromatic heterocyclic five-membered ring derivative having trpv4 inhibitory activity |
| 10/03/2013 | WO2013146649A1 Diquafosol-containing eye drop |
| 10/03/2013 | WO2013144916A1 Tranilast compositions and cocrystals |
| 10/03/2013 | WO2013142912A1 Methods and compositions for reducing ocular discomfort |
| 10/03/2013 | WO2013100660A3 Pharmaceutical composition for treatment of eye pain, containing pge2 synthesis inhibitor |